HALO logo
halo search icon
Cingulate, Inc.
Cingulate, Inc.
CING · NAS

Cingulate, Inc.

US$4.63

Price Arrow0.24 (5.47%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Capital EfficiencyHALO Consensus ValueRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Cingulate, Inc. Overview

CING Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About CING

icon

Website

Cingulate, Inc.

icon

Telephone

1.913.942.2300

icon

Address

1901 West 47th Place, Kansas City, KS 66205

Description

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

CING Price Chart

Key Stats

Market Cap

US$58.28M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.2 - 11.89

Trade Value (12mth)

US$381,382.00

1 week

-3.94%

1 month

-25.09%

YTD

0.23%

1 year

31.83%

All time high

1236.00

Key Fundamentals

EPS 3 yr Growth

-98.80%

EBITDA Margin

0.00%

Operating Cashflow

-$17m

Free Cash Flow Return

-235.40%

ROIC

-306.40%

Interest Coverage

-21.00

Quick Ratio

1.20

Other Data

Shares Outstanding (Fully Diluted)

10m

HALO Sector

Healthcare

Next Company Report Date

05-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CING Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
20 May 26
20 May 26
20 May 26

CING Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-311.99-10.86-4.44locklocklock
EPS (Fully Diluted)
$locklocklocklock-311.99-10.86-4.44locklocklock
Growth
%locklocklocklock16.896.559.1locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Cingulate, Inc. (CING:NAS)?
Halo FAQ
The current share price of Cingulate, Inc. (CING:NAS) is USD$4.63.
What is the 52-week high share price for Cingulate, Inc. (CING:NAS)?
Halo FAQ
The 52-week high share price for Cingulate, Inc. (CING:NAS) is USD$11.89.
What is the 52-week low share price for Cingulate, Inc. (CING:NAS)?
Halo FAQ
The 52-week low share price for Cingulate, Inc. (CING:NAS) is USD$3.20.
What is the dividend yield for Cingulate, Inc. (CING:NAS)?
Halo FAQ
Cingulate, Inc. (CING:NAS) does not pay a dividend.
What was Cingulate, Inc. (CING:NAS) last dividend payment?
Halo FAQ
Cingulate, Inc. (CING:NAS) does not pay a dividend.
What is the franking level for Cingulate, Inc. (CING:NAS)?
Halo FAQ
Cingulate, Inc. (CING:NAS) has a franking level of 0.00%.
In which sector is Cingulate, Inc. (CING:NAS) classified?
Halo FAQ
Cingulate, Inc. (CING:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.